Relationship Between Neutrophil-Lymphocyte Ratio and Drug-Coated Balloon Restenosis in Patients With Femoropopliteal

Tao Pan1, Shi-Yun Tian2, Zhen Liu1

  • 1Department of the Interventional Therapy, 74710First Affiliated Hospital of Dalian Medical University, Dalian, China.

Angiology
|May 16, 2022
PubMed

Insights

The neutrophil-lymphocyte ratio (NLR) predicts late restenosis after drug-coated balloon angioplasty for femoropopliteal arterial disease. Higher postoperative NLR levels are associated with an increased risk of restenosis.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Biomarkers in Cardiovascular Disease

Background:

  • Femoropopliteal arterial disease is a common cause of peripheral artery disease.
  • Drug-coated balloon (DCB) angioplasty is a treatment option, but restenosis remains a challenge.
  • Identifying predictors of restenosis is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between neutrophil-lymphocyte ratio (NLR) and restenosis in patients undergoing DCB angioplasty for femoropopliteal arterial disease.
  • To determine if NLR is an independent predictor of late restenosis.
  • To establish a potential cutoff value for NLR in predicting restenosis.

Main Methods:

  • Retrospective analysis of 120 patients treated with DCB angioplasty.
  • Patients were categorized based on restenosis development and timing.
  • Multivariate logistic regression and ROC curve analysis were used to assess NLR's predictive value.

Main Results:

  • Postoperative NLR was significantly higher in the late-restenosis group compared to the no-restenosis group (3.53 vs 2.70, p=0.011).
  • Postoperative NLR independently predicted late restenosis (OR 1.404, p=0.014).
  • A cutoff NLR of 2.78 showed 80.8% sensitivity and 53.2% specificity for predicting late restenosis, with a higher incidence in patients with NLR ≥ 2.78 (32.3% vs 9.1%, p=0.002).

Conclusions:

  • Postoperative neutrophil-lymphocyte ratio is an independent predictor of late restenosis in patients with femoropopliteal arterial disease treated with DCB angioplasty.
  • NLR may serve as a valuable biomarker for risk stratification in these patients.
  • Further prospective studies are warranted to confirm these findings.

Related Concept Videos